Ayurvedic drug BGR-34 effective against obesity, diabetes: AIIMS
AIIMS study has found that the ayurvedic drug BGR-34 can help people lose weight and reduce blood sugar levels.
As per a study conducted by the All India Institute of Medical Sciences (AIIMS), the Ayurvedic drug BGR-34 can help people lose weight and reduce blood sugar levels.
The study found that this Ayurvedic diabetic treatment aids in weight loss and enhances the body's metabolic system. This medication was found a few years ago by CSIR (Council for Scientific and Industrial Research) researchers.
"BGR-34 was utilised in this three-year trial along with several other anti-diabetic allopathic medications. The purpose of this study was to see whether the findings were more potent when taken with allopathic medications. The outcomes were pleasing," said Dr Sudhir Kumar, Sarangi, Professor in the Department of Pharmacology at AIIMS, as reported by DNA India.
The study found that it alone is quite successful at lowering blood sugar levels and also has some additional advantages, such as preventing obesity. Researchers claim that medications including Daruharidra, Giloy, Vijaysar, Gudmar, Majith, and Maithika reduce a patient's blood glucose level and boost their antioxidant levels.
Hormone profiles, lipid profiles, and triglyceride levels were also found to be balanced during this period, and there was a decrease in leptin, which aids in controlling body fat. Similarly, triglycerides, and bad cholesterol, have also been reported to decrease.
In addition to triglycerides, total cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol were observed during the study.
Read more:
Follow Shiksha.com for latest education news in detail on Exam Results, Dates, Admit Cards, & Schedules, Colleges & Universities news related to Admissions & Courses, Board exams, Scholarships, Careers, Education Events, New education policies & Regulations.
To get in touch with Shiksha news team, please write to us at news@shiksha.com

Comments
Latest News
Next Story